Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENZALUTAMIDE Cause Clostridium difficile colitis? 21 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Clostridium difficile colitis have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.

21
Reports of Clostridium difficile colitis with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
7
Deaths
12
Hospitalizations

How Dangerous Is Clostridium difficile colitis From ENZALUTAMIDE?

Of the 21 reports, 7 (33.3%) resulted in death, 12 (57.1%) required hospitalization, and 2 (9.5%) were considered life-threatening.

Is Clostridium difficile colitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does ENZALUTAMIDE Cause?

Fatigue (8,891) Death (6,680) Malignant neoplasm progression (4,696) Prostatic specific antigen increased (3,731) Asthenia (3,589) Drug ineffective (3,468) Hot flush (3,144) Decreased appetite (3,069) Nausea (2,898) Dizziness (2,776)

What Other Drugs Cause Clostridium difficile colitis?

CYCLOPHOSPHAMIDE (717) PREDNISONE (619) DEXAMETHASONE (575) METHOTREXATE (562) ETOPOSIDE (503) CYTARABINE (489) VINCRISTINE (482) LENALIDOMIDE (388) METHYLPREDNISOLONE (385) CIPROFLOXACIN (378)

Which ENZALUTAMIDE Alternatives Have Lower Clostridium difficile colitis Risk?

ENZALUTAMIDE vs EPCORITAMAB ENZALUTAMIDE vs EPCORITAMAB-BYSP ENZALUTAMIDE vs EPERISONE ENZALUTAMIDE vs EPHEDRINE ENZALUTAMIDE vs EPINASTINE

Related Pages

ENZALUTAMIDE Full Profile All Clostridium difficile colitis Reports All Drugs Causing Clostridium difficile colitis ENZALUTAMIDE Demographics